| CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease (NCT05257967) | British Columbia Cancer Agency | 2022-07-18 |
| Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer (NCT05385185) | Hebei Medical University | 2022-05-01 |
| Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation (NCT05146219) | TYK Medicines, Inc | 2022-04-02 |
| Standardized Clinical Assessment of Patients With Leptomeningeal Metastasis (NCT06417710) | University of Zurich | 2022-01-30 |
| Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases (NCT05034497) | Plus Therapeutics | 2021-12-06 |
| Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis (NCT04944069) | Second Affiliated Hospital of Nanchang University | 2021-07-01 |
| Clinical Efficacy and Safety of EGFR-TKI Combined With Nimotuzumab in the Treatment of Leptomeningeal Metastases From Lung Cancer (NCT04833205) | Hui Bu | 2021-04-19 |
| A Dose Exploration Study of Almonertinib for EGFRm NSCLC Patients With Brain/Leptomeningeal Metastasis (ARTISTRY) (NCT04778800) | Henan Cancer Hospital | 2021-03-20 |
| Pembrolizumab And Lenvatinib In Leptomeningeal Metastases (NCT04729348) | Massachusetts General Hospital | 2021-03-08 |
| Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease (NCT04588545) | H. Lee Moffitt Cancer Center and Research Institute | 2020-12-10 |
| Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation (NCT04233021) | Intergroupe Francophone de Cancerologie Thoracique | 2020-07-16 |
| Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis (NCT04356222) | Hui Bu | 2020-06-01 |
| Efficacy and Safety of Recombinant Human Endostatin in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis (NCT04356118) | Hui Bu | 2020-06-01 |
| DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease (NCT04420598) | MedSIR | 2020-05-25 |
| Firmonertinib in the Treatment of EGFR(+) NSCLC Patients With Central Nervous System Metastasis (NCT07239102) | Beijing Tiantan Hospital | 2020-01-01 |
| GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases (NCT04192981) | Memorial Sloan Kettering Cancer Center | 2019-12-06 |
| Osimertinib With or Without Bevacizumab for EGFR- Mutant Non-small Cell Lung Cancer With Leptomeningeal Metastasis (NCT04148898) | Second Affiliated Hospital of Nanchang University | 2019-11-01 |
| Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis. (NCT03974204) | Centre Oscar Lambret | 2019-07-01 |
| Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors (NCT03507244) | The First Hospital of Jilin University | 2018-04-12 |
| Osimertinib With Bevacizumab for Leptomeningeal Metastasis From EGFR-mutation Non-Small Cell Lung Cancer (NCT04425681) | Second Affiliated Hospital of Nanchang University | 2017-10-01 |
| Microfluidic Device to Diagnose Leptomeningeal Metastasis in Breast Cancer (NCT02948751) | Columbia University | 2017-02-06 |
| Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastases From Solid Tumors (NCT03082144) | The First Hospital of Jilin University | 2017-02-01 |
| Tomotherapy for Leptomeningeal Metastases (NCT04178343) | Chinese Academy of Medical Sciences | 2014-09-01 |
| Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM) (NCT02071056) | Dartmouth-Hitchcock Medical Center | 2014-05-01 |
| A Multi-center Prospective Observational Biomarker Study on EGFRm+ Non-small Cell Lung Cancer Patients With Leptomeningeal Metastasis (NCT02803619) | Peking Union Medical College Hospital | 2013-11-01 |
| Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal Metastasis (NCT01281696) | National Taiwan University Hospital | 2011-01-01 |